These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23145135)

  • 1. Cell penetrable humanized-VH/V(H)H that inhibit RNA dependent RNA polymerase (NS5B) of HCV.
    Thueng-in K; Thanongsaksrikul J; Srimanote P; Bangphoomi K; Poungpair O; Maneewatch S; Choowongkomon K; Chaicumpa W
    PLoS One; 2012; 7(11):e49254. PubMed ID: 23145135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity.
    Phalaphol A; Thueng-In K; Thanongsaksrikul J; Poungpair O; Bangphoomi K; Sookrung N; Srimanote P; Chaicumpa W
    J Virol Methods; 2013 Dec; 194(1-2):289-99. PubMed ID: 24036073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase.
    Nikonov A; Juronen E; Ustav M
    J Biol Chem; 2008 Aug; 283(35):24089-102. PubMed ID: 18574240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HCV replication by humanized-single domain transbodies to NS4B.
    Glab-Ampai K; Malik AA; Chulanetra M; Thanongsaksrikul J; Thueng-In K; Srimanote P; Tongtawe P; Chaicumpa W
    Biochem Biophys Res Commun; 2016 Aug; 476(4):654-664. PubMed ID: 27240954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanized-VHH transbodies that inhibit HCV protease and replication.
    Jittavisutthikul S; Thanongsaksrikul J; Thueng-In K; Chulanetra M; Srimanote P; Seesuay W; Malik AA; Chaicumpa W
    Viruses; 2015 Apr; 7(4):2030-56. PubMed ID: 25903832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized-single domain antibodies (VH/VHH) that bound specifically to Naja kaouthia phospholipase A2 and neutralized the enzymatic activity.
    Chavanayarn C; Thanongsaksrikul J; Thueng-In K; Bangphoomi K; Sookrung N; Chaicumpa W
    Toxins (Basel); 2012 Jul; 4(7):554-67. PubMed ID: 22852068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of hepatitis C virus RNA polymerases ser29 and ser42 by protein kinase C-related kinase 2 regulates viral RNA replication.
    Han SH; Kim SJ; Kim EJ; Kim TE; Moon JS; Kim GW; Lee SH; Cho K; Yoo JS; Son WS; Rhee JK; Han SH; Oh JW
    J Virol; 2014 Oct; 88(19):11240-52. PubMed ID: 25031343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of B cell epitopes of hepatitis C virus RNA dependent RNA polymerase.
    Hou L; Du G; Tong Y; Wang H
    J Virol Methods; 2002 Jun; 104(1):1-8. PubMed ID: 12020787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors.
    Nyanguile O; Pauwels F; Van den Broeck W; Boutton CW; Quirynen L; Ivens T; van der Helm L; Vandercruyssen G; Mostmans W; Delouvroy F; Dehertogh P; Cummings MD; Bonfanti JF; Simmen KA; Raboisson P
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4420-31. PubMed ID: 18852280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibodies that specifically recognize the palm subdomain of hepatitis C virus nonstructural protein 5B polymerase.
    Ingravallo P; Lahser F; Xia E; Sodowich B; Lai VC; Hong Z; Zhong W
    Virus Res; 2001 Jun; 75(2):179-87. PubMed ID: 11325472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors.
    Biswal BK; Cherney MM; Wang M; Chan L; Yannopoulos CG; Bilimoria D; Nicolas O; Bedard J; James MN
    J Biol Chem; 2005 May; 280(18):18202-10. PubMed ID: 15746101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase.
    Moradpour D; Bieck E; Hügle T; Wels W; Wu JZ; Hong Z; Blum HE; Bartenschlager R
    J Biol Chem; 2002 Jan; 277(1):593-601. PubMed ID: 11641406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention.
    Ahmed-Belkacem A; Guichou JF; Brillet R; Ahnou N; Hernandez E; Pallier C; Pawlotsky JM
    Nucleic Acids Res; 2014 Aug; 42(14):9399-409. PubMed ID: 25053847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational Analysis of Hepatitis C Virus NS5B in the Subgenomic Replicon Cell Culture.
    Ma Y; Shimakami T; Luo H; Hayashi N; Murakami S
    J Biol Chem; 2004 Jun; 279(24):25474-82. PubMed ID: 15037608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity.
    Lohmann V; Körner F; Herian U; Bartenschlager R
    J Virol; 1997 Nov; 71(11):8416-28. PubMed ID: 9343198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations.
    Manjula S; Sivanandam M; Kumaradhas P
    J Biomol Struct Dyn; 2019 Jun; 37(9):2440-2456. PubMed ID: 30047829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.
    Herlihy KJ; Graham JP; Kumpf R; Patick AK; Duggal R; Shi ST
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3523-31. PubMed ID: 18694956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody recognizing N-terminal epitope of hepatitis C virus nonstructural 5B inhibits viral RNA replication.
    Kang SM; Choi SH; Park CY; Kim MH; Kim TK; Park JM; Koh MS; Kang HJ; Hwang SB
    J Viral Hepat; 2008 Apr; 15(4):305-13. PubMed ID: 18307593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive structure-function comparison of hepatitis C virus strain JFH1 and J6 polymerases reveals a key residue stimulating replication in cell culture across genotypes.
    Schmitt M; Scrima N; Radujkovic D; Caillet-Saguy C; Simister PC; Friebe P; Wicht O; Klein R; Bartenschlager R; Lohmann V; Bressanelli S
    J Virol; 2011 Mar; 85(6):2565-81. PubMed ID: 21209117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.